Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWVIRIP is an HIV entry inhibitor (IC50 = 26 µM) and a peptide fragment of the serine protease inhibitor alpha-1 antitrypsin.1,2 It is produced by C-terminal cleavage of alpha-1 antitrypsin by matrix metalloproteinase-7 (MMP-7).2 VIRIP (100 µM) inhibits HIV-1 replication in isolated human peripheral blood mononuclear cells (PBMCs) and transmission by monocyte-derived dendritic cells to primary T cells.1 Plasma levels of VIRIP are increased in patients with HIV infection.2
WARNING This product is not for human or veterinary use.
1. Discovery and optimization of a natural HIV-
2. Elevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-